FITB vs PLX · P/E 17, rev $3.37B vs P/E 31, rev $53.6M
Fifth Third Bancorp (FITB) versus Protalix Biotherapeutics Inc (PLX) — a side-by-side from cached financials, not a winner call.
Fifth Third Bancorp (FITB) is a banks - regional company listed on US.
Protalix Biotherapeutics Inc (PLX) is a biotechnology company listed on US.
Latest reported FITB revenue for 2026-06-30 was $3.37B. Net income was $801.0M. Revenue was up 13.5% from 2026-03-31 to 2026-06-30. FITB currently screens at market cap $45.25B and trailing P/E 16.8.
Latest reported PLX revenue for 2026-06-30 was $53.6M. Net income was $22.1M. Revenue was up 59.0% from 2026-03-31 to 2026-06-30. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
FITB currently screens at market cap $45.25B and trailing P/E 16.8. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
Not investment advice. Open the FITB and PLX stock pages for the full models.
Not investment advice.